Skip to main content

Advertisement

Log in

Lymph node ratio, number of excised nodes and sentinel-node concepts in breast cancer

  • Letter to the Editor
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Pepels MJ, Vestjens JHMJ, de Boer M et al. (2010) Safety of avoiding routine use of axillary dissection in early stage breast cancer: a systematic review. Breast Cancer Res Treat. doi:10.1007/s10549-010-1210-7

  2. Krag DN, Anderson SJ, Julian TB et al (2010) Sentinel-lymph-node resection compared with conventional axillary lymph–node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 11:927–933

    Article  PubMed  Google Scholar 

  3. Veronesi U, Viale G, Paganelli G et al (2010) Sentinel node biopsy in breast cancer. Ten year results of a randomized controlled study. Ann Surg 251:595–600

    Article  PubMed  Google Scholar 

  4. Moon HG, Han W, Noh DY (2010) Comparable survival between pN0 breast cancer patients undergoing sentinel node biopsy and extensive axillary dissection: a report from the Korean breast cancer society. J Clin Oncol 28:1692–1699

    Article  PubMed  Google Scholar 

  5. Sanghani M, Balk EM, Cady B (2009) Impact of axillary lymph node dissection on breast cancer outcome in clinically node negative patients. Cancer 115:1613–1620

    Article  PubMed  Google Scholar 

  6. Vinh-Hung V, Verkooijen HM, Fioretta G et al (2009) Lymph node ratio as an alternative to pN staging in node-positive breast cancer. J Clin Oncol 27:1062–1068

    Article  PubMed  Google Scholar 

  7. Danko ME, Bennett KM, Zhai J et al (2010) Improved staging in node-positive breast cancer patients using lymph node ratio: results in 1788 patients with long-term follow-up. J Am Coll Surg 210:797–807

    Article  PubMed  Google Scholar 

  8. Troung PT, Lesperance M, Li KH et al (2010) Micrometastatic node-positive breast cancer: long-term outcomes and identification of high-risk subsets in a large population-based series. Ann Surg Oncol 17:2138–2146

    Article  Google Scholar 

  9. Axelsson CK, Durino M, Christansen PM et al (2009) Impact on regional recurrence and survival of axillary surgery in women with node-negative primary breast cancer. Br J Surg 96:40–46

    Article  PubMed  CAS  Google Scholar 

  10. Wasif N, Maggard MA, Ko CY et al (2010) Underuse of axillary dissection for management of sentinel node micrometastases in breast cancer. Arch Surg 145:161–166

    Article  PubMed  Google Scholar 

  11. Straver ME, Meijnen P, van Tienhoven G et al (2010) Sentinel node identification rate and nodal involvement in the EORTC 10981–22023 AMAROS Trial. Ann Surg Oncol 17:1854–1861

    Article  PubMed  Google Scholar 

  12. Maaskant-Braat AJ, van de Poll-Franse LV, Voogd AC et al. (2010) Sentinel node micrometastases in breast cancer do not affect prognosis: a population-based study. Breast Cancer Res Treat. doi: 10.1007s10549-010-1086-6

    PubMed  Google Scholar 

  13. de Boer M, van Deurzen C, van Dijck JAAM et al (2009) Micrometastases or isolated tumor cells and the outcome of breast cancer. N Engl J Med 361:653–663

    Article  PubMed  Google Scholar 

  14. Anderson SJ, Wapnir I, Dignam JJ et al (2009) Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five national surgical adjuvant breast and bowel project protocols of node-negative breast cancer. J Clin Oncol 27:2466–2473

    Article  PubMed  Google Scholar 

  15. Xing Y, Badgwell BD, Ross MI et al (2009) Lymph node ratio predicts disease-specific survival in melanoma patients. Cancer 115:2505–2513

    Article  PubMed  Google Scholar 

References for Rebuttal letter

  1. Peparini N, Chirletti P (2010) Lymph node ratio, number of excised nodes and sentinel-node concepts in breast cancer. Breast Cancer Res Treat. doi:10.1007/s10549-010-1296-y

    PubMed  Google Scholar 

  2. Pepels MJ, Vestjens JHMJ, de Boer M et al. (2010) Safety of avoiding routine use of axillary dissection in early stage breast cancer: a systematic review. Breast Cancer Res Treat doi:10.1007/s10549-010-1210-7

  3. Woodward WA, Vinh-Hung V, Ueno NT et al (2006) Prognostic value of nodal ratios in node-positive breast cancer. J Clin Oncol 24:2910–2916

    Article  PubMed  Google Scholar 

  4. Truong PT, Lesperance M, Li KH et al (2010) Micrometastatic node-positive breast cancer: long-term outcomes and identification of high-risk subsets in a large population-based series. Ann Surg Oncol 17:2138–2146

    Article  PubMed  Google Scholar 

  5. Danko ME, Bennett KM, Zhai J et al (2010) Improved staging in node-positive breast cancer patients using lymph node ratio: results in 1788 patients with long-term follow-up. J Am Coll Surg 210:797–807

    Article  PubMed  Google Scholar 

  6. Vinh-Hung V, Verkooijen HM, Fioretta G et al (2009) Lymph node ratio as an alternative to pN staging in node-positive breast cancer. J Clin Oncol 27:1062–1068

    Article  PubMed  Google Scholar 

  7. Moon HG, Han W, Noh DY (2010) Comparable survival between pN0 breast cancer patients undergoing sentinel node biopsy and extensive axillary dissection: a report from the Korean breast cancer society. J Clin Oncol 28:1692–1699

    Article  PubMed  Google Scholar 

  8. Axelsson CK, Durino M, Christansen PM et al (2009) Impact on regional recurrence and survival of axillary surgery in women with node-negative primary breast cancer. Br J Surg 96:40–46

    Article  PubMed  CAS  Google Scholar 

  9. Van Deurzen CH, de Boer M, Monninkhof EM et al (2008) Non-sentinel lymph node metastases associated with isolated breast cancer cells in the sentinel node. J Natl Cancer Inst 100:1574–1580

    Article  PubMed  Google Scholar 

  10. de Boer M, van Deurzen C, van Dijck JAAM et al (2009) Micrometastases or isolated tumor cells and the outcome of breast cancer. N Engl J Med 361:653–663

    Article  PubMed  Google Scholar 

  11. Pugliese M, Stempel M, Patil S et al (2010) The clinical impact and outcomes of immunohistochemistry-only metastasis in breast cancer. Am J Surg 200:368–373

    Article  PubMed  Google Scholar 

  12. Leidenius MH, Vironen JH, Heikkilä PS et al (2010) Influence of isolated tumor cells in sentinel nodes on outcome in small, node-negative (pT1N0M0) breast cancer. Ann Surg Oncol 17:254–262

    Article  PubMed  Google Scholar 

  13. Hansen NM, Grube B, Ye X et al (2009) Impact of micrometastases in the sentinel node of patients with invasive breast cancer. J Clin Oncol 27:4679–4684

    Article  PubMed  Google Scholar 

  14. Maaskant-Braat AJ, van de Poll-Franse LV, Voogd AC et al. (2010) Sentinel node micrometastases in breast cancer do not affect prognosis: a population-based study. Breast Cancer Res Treat. doi: 10.1007s10549-010-1086-6

  15. Andersson Y, Frisell J, Sylvan M et al (2010) Breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes. J Clin Oncol 28:2868–2873

    Article  PubMed  Google Scholar 

  16. de Boer M, van Dijck JAAM, Bult P et al (2010) Breast cancer prognosis and occult lymph node metastases, isolated tumor cells, and micrometastases. J Natl Cancer Inst 102:410–425

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nadia Peparini.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Peparini, N., Chirletti, P. Lymph node ratio, number of excised nodes and sentinel-node concepts in breast cancer. Breast Cancer Res Treat 126, 829–833 (2011). https://doi.org/10.1007/s10549-010-1296-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-010-1296-y

Keywords

Navigation